SCHEMBL382114

SCHEMBL382114

Cc1cc(C)c(S(=O)(=O)NC(CC(=O)O)NC(=O)c2ccc(N3CCC(Nc4nc5ccccc5[nH]4)CC3)cc2)c(C)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ITGAV P06756 9/20 0.46
ITGB3 P05106 8/20 0.46
ITGB1 P05556 4/20 0.41
ITGA5 P08648 3/20 0.41
ITGA2B P08514 2/20 0.41
TP53 P04637 2/20 0.40
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
PKM P14618 1/20 0.38
OPRK1 P41145 1/20 0.38
KLF5 Q13887 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CASR P41180 1/20 0.37
MAPT P10636 1/20 0.37
KCNH2 Q12809 2/20 0.37
MAPK1 P28482 1/20 0.37
ADRB3 P13945 1/20 0.37
PTGDR Q13258 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL382991 0.89 ITGB3 (0.47) ITGAVITGB3ITGA2BTP53NPC1
SCHEMBL383120 0.86 ITGB3 (0.43) ITGAVITGB3ITGA2BTP53NPC1
SCHEMBL382113 0.86 ITGAV (0.53) ITGAVITGB3ITGB1ITGA5ITGA2B
SCHEMBL382427 0.86 ITGB3 (0.43) ITGAVITGB3ITGA2BTP53NPC1
SCHEMBL382319 0.84 MAPT (0.47) ITGAVITGB3ITGA2BTP53NPC1
SCHEMBL381930 0.80 ITGB3 (0.48) ITGAVITGB3TP53NPC1RAB9A
SCHEMBL382575 0.80 SMN1; SMN2 (0.36) ITGAVITGB3ITGA2BMEN1KMT2A
SCHEMBL382383 0.80 ITGB3 (0.47) ITGAVITGB3ITGB1ITGA5ITGA2B
SCHEMBL382282 0.79 ITGB3 (0.60) ITGAVITGB3ITGB1ITGA5ITGA2B
SCHEMBL6500812 0.77 ITGAV (0.39) ITGAVITGB3ITGB1ITGA5ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420558-B1 COMPOUNDS WITH AMIDINE GROUPS ANTAGONISTIC ACTIVITY, CELL ADHESION INHIBITORY ACTIVITY, HUMAN PLATELET AGGREGATION INHIBITORY ACTIVITY, AND THERAPEUTIC AGENTS MEIJI SEIKA KAISHA, LTD. (JP) 2002-07-16 US claimed
EP-1074543-B1 AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS MEIJI SEIKA PHARMA CO LTD (JP) 2012-01-25 EP disclosed
US-6420558-B1 COMPOUNDS WITH AMIDINE GROUPS ANTAGONISTIC ACTIVITY, CELL ADHESION INHIBITORY ACTIVITY, HUMAN PLATELET AGGREGATION INHIBITORY ACTIVITY, AND THERAPEUTIC AGENTS MEIJI SEIKA KAISHA, LTD. (JP) 2002-07-16 US disclosed
EP-1074543-A1 AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS MEIJI SEIKA KAISHA LTD. (JP) 2001-02-07 EP disclosed